<DOC>
	<DOCNO>NCT00854867</DOCNO>
	<brief_summary>The purpose study demonstrate safety give Whole Brain Radiotherapy ( WBRT ) together intrathecal liposomal cytarabine ( DepoCyte® ) patient leptomeningeal metastasis . The study compare safety give DepoCyte time WBRT give drug WBRT complete .</brief_summary>
	<brief_title>Study Demonstrate Safety WBR Administered Same Time Intrathecal Liposomal Cytarabine ( DepoCyte® ) Versus Intrathecal Liposomal Cytarabine ( DepoCyte® ) Administered After WBR Treatment Solid Tumour Neoplastic Meningitis Patients With Without Brain Metastasis .</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningeal Carcinomatosis</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>Indication Criteria Inclusion/Exclusion : Subjects include study meet follow criterion : Informed consent Male female , age 18 year Solid tumour neoplastic meningitis demonstrate positive lumbar CSF cytology ( obtain within 21 day prior treatment initiation ) OR Characteristic sign symptom neoplastic meningitis PLUS MRI indicate presence meningeal tumour ( diagnosis make neurooncologist confirm / sign within CRF ) . All MRIs forward central review confirmation diagnosis . In case discrepancy central review override assessment investigator . CSF flow abnormality exclude either MRI scan 99TcDTPA 111InDTPA flow study . ( If flow abnormality initially demonstrate flow block subsequently document another flow study MRI scan relieve follow limited field radiation therapy , subject may eligible ) If brain metastasis confirm ( include subject previous stereotactical radiosurgery solitary lesion brain surgery ) lesion le 3cm diameter Mini Mental State Examination ( MMSE ) score 24 ECOG performance status 02 Laboratory value follow : Platelet count equal 80,000/mm3 ANC equal 1,000/mm3 Serum creatinine less equal 2 x upper limit normal Total bilirubin less equal 3 x upper limit normal SGOT ( AST ) less equal 3 x upper limit normal LDH le equal 3 x upper limit normal Females childbearing potential must negative ( urine serum ) pregnancy test within 21 day prior start study treatment . Females childbearing potential must willing use effective method contraception prevent pregnancy duration study ( e.g . implant , combine oral contraceptive , intrauterine device ( IUDs ) , sexual abstinence vasectomise partner ) . Males must willing use effective method contraception partner prevent pregnancy duration study ( e.g . implant , combine oral contraceptive , intrauterine device ( IUDs ) , sexual abstinence vasectomy ) . Previous WBRT Brain metastases 3 cm diameter Previous IT treatment Uncontrolled infection include HIV infection Any present condition regard contraindication WBRT intrathecal chemotherapy Prior treatment systemic ARAC Anticipated hypersensitivity DepoCyte ARAC Clinically manifest encephalopathy On anticoagulant therapy Ventricular peritoneal CSF drain situ Subjects unable comply study procedure Pregnancy lactation Any investigational drug administer within 21 day prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Solid tumour neoplastic meningitis</keyword>
	<keyword>STNM</keyword>
	<keyword>leptomeningeal metastasis</keyword>
	<keyword>DepoCyte</keyword>
	<keyword>WBRT</keyword>
	<keyword>Whole Brain Radiotherapy</keyword>
	<keyword>Liposomal cytarabine intrathecal</keyword>
	<keyword>Solid Tumour Neoplastic Meningitis without brain metastasis</keyword>
</DOC>